Morgan Griffith (R-Va.) would make it easier for patients to join clinical trials and shorten the time it takes ...

He opened by drawing a clear distinction between point solutions and embedded AI: when each function—protocol design, feasibility, monitoring, data review—uses AI in isolation, task efficiencies ...

Syneos Health and Optum have announced a partnership to build what they describe as a more adaptive and connected model for ...

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, ...

Growing recognition of obesity as a complex, multi-system chronic disease is driving a corresponding increase in the complexity of weight management, including obesity clinical trials. As development ...

CRIO’s chief innovation officer, Mike Wenger touches on the two ways sites get AI adoption wrong. Mike Wenger, chief ...

Sequoia’s Dan White and Dr. Tom Kreamer touch on why sponsors and CROs should treat a site network as one centralized ...

Kurt Mussina, CEO, Paradigm Clinical Research, describes his organization’s nine locations not as separately managed sites, ...

Javara CEO Jennifer Byrne talks about the requirements for embedding clinical trials directly into physician practices and why solving the “last mile” of trial participation means building ...

What sponsors and sites should know about the AstraZeneca-Oracle AI collaboration on trial recruitment, safety monitoring and data governance. AstraZeneca and Oracle Health and Life Sciences have ...

Jennifer Byrne, CEO and founder, Javara, credits SCRS as a valuable part of the broader site landscape, pointing to its role ...

Kurt Mussina, CEO, Paradigm Clinical Research, acknowledges that scale matters but pushes back on the idea that it should ...